FDA, EU diverge on AstraZeneca COVID-19 vaccine

FDA, EU diverge on AstraZeneca COVID-19 vaccine

By Excelsio Media on October 01, 2020 Also in covid-19, fda

The FDA has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)